Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASSEMBLY BIOSCIENCES, INC. Director's Dealing 2016

Jun 3, 2016

33081_dirs_2016-06-03_30547517-837f-47d4-8dc6-5a105541a864.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2016-06-02

Reporting Person: Rollins Thomas E (See Remarks)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-06-02 Stock Option (Right to Buy) $6.36 A 40263 Acquired 2026-02-17 Common Stock (40263) Direct

Footnotes

F1: The Compensation Committee of the Issuer approved the grant of a stock option to purchase 40,263 shares of Common Stock at an exercise price of $6.36 per share to the Reporting Person on February 17, 2016. This grant was approved subject to and contingent upon approval by the stockholders of the Company at its 2016 annual meeting of the amendment to the 2014 Stock Incentive Plan (the "Amendment"), to increase the shares authorized for issuance thereunder. On June 2, 2016, the stockholders of the Issuer approved the Amendment.

F2: The shares of common stock subject to the option shall vest and become exercisable in four (4) equal annual installments over a four-year period, with each installment vesting upon the anniversary of January 11, 2016, such that the option shall be fully vested and exercisable on January 11, 2020.